J.P. Eschard
Impact in
- Rheumatology top 5%
- Osteoarthritis Treatment and Mechanisms
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
-
- Autoimmune and Inflammatory Disorders Research
Papers in
- Oncology 6
- Bone health and treatments 3
- Peptidase Inhibition and Analysis 2
-
- Inflammasome and immune disorders 2
- Co-authors
- Damien Jolly (2 shared papers)Françis Guillemin (2 shared papers)Jean‐Hugues Salmon (1 shared paper)Anne‐Christine Rat (1 shared paper)Jérémie Sellam (1 shared paper)M. Michel (1 shared paper)Jean Sibilia (2 shared papers)Daniel Wendling (2 shared papers)
- Journals
- Lara D. Veeken (2 papers)European Journal of Orthopaedic Surgery & Traumatology (2 papers)Osteoarthritis and Cartilage (1 paper)Vaccine (1 paper)Clinical Nuclear Medicine (1 paper)
- Partner nations
- FranceNetherlandsIndonesia
In The Last Decade
J.P. Eschard
16 papers receiving 387 citations
Peers
Comparison fields: 5 of 64
- Rheumatology 174
- Hematology 33
- Hepatology 22
- Emergency Medicine 22
- Immunology and Allergy 15
Countries citing papers authored by J.P. Eschard
This map shows the geographic impact of J.P. Eschard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Eschard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Eschard more than expected).
Fields of papers citing papers by J.P. Eschard
This network shows the impact of papers produced by J.P. Eschard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Eschard. The network helps show where J.P. Eschard may publish in the future.
Co-authors
The 25 scholars most cited alongside J.P. Eschard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 153 | |
| 2 | 1999 | 112 | |
| 3 | A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritis. | 1998 | 34 |
| 4 | 1997 | 20 | |
| 5 | 2015 | 19 | |
| 6 | Distribution of fibronectin in diabetic skin. | 1983 | 19 |
| 7 | 1994 | 13 | |
| 8 | 1993 | 12 | |
| 9 | [Osteoarticular manifestations of sarcoidosis]. | 1994 | 10 |
| 10 | 2017 | 9 | |
| 11 | [Carriage of HBs antigen in pregnant women and spread of the virus in their family]. | 1985 | 2 |
| 12 | 1992 | 2 | |
| 13 | 1997 | 1 | |
| 14 | 1997 | 1 | |
| 15 | 1987 | 1 | |
| 16 | 1993 | 1 | |
| 17 | 2006 | 1 | |
| 18 | 1990 | 0 |
About J.P. Eschard
J.P. Eschard is a scholar working on Oncology, Molecular Biology, Surgery, Rheumatology and Orthopedics and Sports Medicine, having authored 18 papers that have together received 410 indexed citations. Recurring topics across this work include Orthopedic Infections and Treatments (3 papers), Bone and Joint Diseases (3 papers), Bone health and treatments (3 papers), Inflammatory Myopathies and Dermatomyositis (2 papers), Inflammasome and immune disorders (2 papers), Peptidase Inhibition and Analysis (2 papers), Orthopedic Surgery and Rehabilitation (1 paper) and Osteoarthritis Treatment and Mechanisms (1 paper). The work is most often cited by research in Rheumatology (174 citations), Hematology (33 citations), Hepatology (22 citations), Emergency Medicine (22 citations) and Immunology and Allergy (15 citations). J.P. Eschard has collaborated with scholars based in France, Netherlands and Indonesia. Frequent co-authors include Damien Jolly, Françis Guillemin, Jean‐Hugues Salmon, Anne‐Christine Rat, Jérémie Sellam, M. Michel, Jean Sibilia, Daniel Wendling, Éric Toussirot and E. Vignon. Their work appears in journals such as Lara D. Veeken, European Journal of Orthopaedic Surgery & Traumatology, Osteoarthritis and Cartilage, Vaccine and Clinical Nuclear Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.